Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food-effect Study of ModraDoc006/r in Solid Tumors
NCT03147378Phase 1Completed
- Sponsor
- Modra Pharmaceuticals
- Start
- May 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ModraDoc006 in solid tumor (2 arms), sponsored by Modra Pharmaceuticals. Primary endpoints: Area Under the Curve of Docetaxel and Peak Concentration of Docetaxel. Started May 2017; status: completed.
02
Drugs
ModraDoc006
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT03147378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03147378.